Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 200 of 885 entries
View as:

A Study of JNJ-87890387 for Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT06178614 Org: User:
Start: 12/14/23 End: 12/21/27 Due: 12/21/28

Effect of Food on a Fixed Dose Combination Tablet of Canagliflozin and Metformin Immediate Release in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01459094 Org: User:
Start: 10/31/11 End: 12/31/11 Due: 12/31/12

A Study of JNJ-75348780 in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)

Phase: N/A Priority: Normal
NCT ID: NCT04540796 Org: User:
Start: 11/20/20 End: 10/31/25 Due: 10/31/26

A Pivotal Bioequivalence Study of DOXIL/CAELYX (Doxorubicin HCL) in Patients With Advanced or Refractory Solid Malignancies Including Patients With Ovarian Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01815294 Org: User:
Start: 05/31/13 End: 12/31/14 Due: 12/31/15

A Study of Safety, Pharmacokinetics and Pharmacodynamics of JNJ-64457107 in Participants With Advanced Stage Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02829099 Org: User:
Start: 09/21/16 End: 07/29/21 Due: 07/29/22

A Study of (14C)-JNJ-73841937 (Lazertinib) in Healthy Male Participants

Phase: N/A Priority: Normal
NCT ID: NCT04410081 Org: User:
Start: 07/14/20 End: 03/02/21 Due: 03/02/22

A Study of Safety, Pharmacokinetics, Pharmacodynamics of JNJ-61610588 in Participants With Advanced Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02671955 Org: User:
Start: 01/31/16 End: 07/31/17 Due: 07/31/18

A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01989754 Org: User:
Start: 01/16/14 End: 02/23/17 Due: 02/23/18

A Study to Investigate the Effect of JNJ-63623872 on Pitavastatin in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT02595268 Org: User:
Start: 11/30/15 End: 01/31/16 Due: 01/31/17

Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research: Prospective Readiness Cohort Study

Phase: N/A Priority: Normal
NCT ID: NCT02114372 Org: User:
Start: 02/05/14 End: 07/10/24 Due: 07/10/25

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

Phase: N/A Priority: Normal
NCT ID: NCT05275023 Org: User:
Start: 06/30/22 End: 05/31/24 Due: 05/31/25

A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men

Phase: N/A Priority: Normal
NCT ID: NCT01588782 Org: User:
Start: 01/31/12 End: 02/29/12 Due: 02/28/13

A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05378906 Org: User:
Start: 06/07/22 End: 09/28/22 Due: 09/28/23

A Study of JNJ-77242113 for the Treatment of Participants With Plaque Psoriasis Involving Special Areas (Scalp, Genital, and/or Palms of the Hands and the Soles of the Feet)

Phase: N/A Priority: Normal
NCT ID: NCT06095102 Org: User:
Start: 10/12/23 End: 06/10/27 Due: 06/10/28

A Study to Assess the Pharmacokinetics and Pharmacodynamics of JNJ-54452840 in Participants With Heart Failure and Anti-beta1-adrenergic Receptor Autoantibodies

Phase: N/A Priority: Normal
NCT ID: NCT01798745 Org: User:
Start: 11/30/14 End: 12/31/15 Due: 12/31/16

A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT06667076 Org: User:
Start: 12/16/24 End: 06/06/29 Due: 06/06/30

A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary Retinopathy

Phase: N/A Priority: Normal
NCT ID: NCT05179460 Org: User:
Start: 10/26/21 End: 05/20/22 Due: 05/20/23

A Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT01863784 Org: User:
Start: 04/30/13 End: 11/30/13 Due: 11/30/14

A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT05455684 Org: User:
Start: 06/22/22 End: 09/18/24 Due: 09/18/25

A Study Comparing Siltuximab Plus Best Supportive Care to Placebo Plus Best Supportive Care in Anemic Patients With International Prognostic Scoring System Low- or Intermediate-1-Risk Myelodysplastic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01513317 Org: User:
Start: 11/30/11 End: 09/30/12 Due: 09/30/13

An Observational Study to Assess the Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Users of Proton Pump Inhibitors, and Users of Metoclopramide

Phase: N/A Priority: Normal
NCT ID: NCT01907633 Org: User:
Start: 12/31/11 End: 12/31/13 Due: 12/31/14

A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastases

Phase: N/A Priority: Normal
NCT ID: NCT04523207 Org: User:
Start: 08/19/20 End: 10/25/23 Due: 10/25/24

A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT04991740 Org: User:
Start: 10/24/21 End: 02/09/23 Due: 02/09/24

A Study to Evaluate the Effectiveness and Safety of CNTO6785 in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT01966549 Org: User:
Start: 11/30/13 End: 09/30/15 Due: 09/30/16

Effect of JNJ 31001074 on Urge to Drink in Alcohol-Dependent Adults

Phase: N/A Priority: Normal
NCT ID: NCT01362699 Org: User:
Start: 08/31/11 End: 08/31/12 Due: 08/31/13